Viewing Study NCT01513135


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2026-05-13 @ 10:42 PM
Study NCT ID: NCT01513135
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2012-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers
Sponsor: Barbara Ensoli, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV, View
None HAART-treated View
None participants View
None Tat protein, View
None Therapeutic immunization View